Volunteer Donate Get Help
 

In the News

The latest news reports, articles, and stories that may be of importance to leukemia and lymphoma patients, caregivers, and family members.

PET Scans Predict Survival Outcomes

Published: May 14, 2018

Author: James Nam, PharmD

Source: Cancer Therapy Advisor

Interim positron-emission tomography (PET) may predict survival, but intensifying treatment based on PET may not improve therapeutic outcomes among patients with aggressive non-Hodgkin lymphoma (NHL), accord ... More >>.


Long-term Survival Improving

Published: May 10, 2018

Author: James Nam, PharmD

Source: Oncology Nurse Advisor

Improvements in the US healthcare system has led to increases of survival among patients with advanced Hodgkin Lymphoma over 3 decades, according to a study in The Oncologist.

Altho ... More >>.


T Cell Biomarker Prediction for CLL Patients

Published: April 30, 2018

Source: University of Pennsylvania School of Medicine

Penn Medicine researchers may have found the reason why some patients with advanced chronic lymphocytic leukemia (CLL) don't respond to chimeric antigen receptor (CAR) T cell therapy, and the answer is tied ... More >>.


Infections: A Cause for Concern Among CLL Patients

Published: April 19, 2018

Author: Bryant Furlow

Source: Cancer Therapy Advisor

Chronic lymphocytic leukemia (CLL), a cancer of the immune system that impairs immune competence, can leave patients vulnerable to infection. Hypogammaglobulinemia and associated respiratory bacterial infect ... More >>.


Dual Immune-Checkpoint Blockade

Published: April 17, 2018

Source: Luxembourg Institute of Health

Chronic lymphocytic leukemia (CLL) is a hematological malignancy that originates in the blood-forming cells of the bone marrow and spreads to other organs through the bloodstream. When infiltrating tissues, ... More >>.


New Standard for Mantle Cell Lymphoma

Published: April 13, 2018

Author: Leah Lawrence

Source: Cancer Therapy Advisor

Combining tow drugs, both of which are active as monotherapies in mantle cell lymphoma (MCL), yielded an overall response rate of 71% in a small study recently published in The New England Journ ... More >>.


FDA Approves New Hodgkin Lymphoma Treatment

Published: March 31, 2018

Author: Andrea Greif

Source: Leukemia & Lymphoma Society

The U.S. Food & Drug Administration today announced the first change in 40 years in the standard way that patients newly diagnosed with advanced Hodgkin lymphoma (HL) should be treated.

Today's F ... More >>.


Renegade Cells Portend Relapse

Published: March 05, 2018

Source: Stanford Medicine

Researchers at the Stanford University School of Medicine have developed a technique that allowed them to determine at diagnosis whether children with acute lymphoblastic leukemia would relapse following tre ... More >>.


Things to Know About CAR T-cell Therapy

Published: February 28, 2018

Author: Cynthia DeMarco

Source: MD Anderson Cancer Center

CAR T-cell therapy is a new type of cancer treatment offered at MD Anderson through clinical trials and FDA-approved standard of care cell therapy products. But what exactly is CAR T-cell therapy? Based on i ... More >>.


Choosing a TKI for CML

Published: February 01, 2018

Author: Bryant Furlow

Source: Cancer Therapy Advisor

The BCR-ABL tyrosine kinase inhibitors (TKIs) were an early example of a successful targeted cancer treatment and have dramatically improved outcomes for patients diagnosed with chronic myeloid leukemia (CML ... More >>.


©2015 Stephanie Robinson Foundation | Privacy Policy